Should we begin using bromocriptine for CVD management during pregnancy per ESC guidelines in patients with peripartum cardiomyopathy?  

The use of bromocriptine for managing cardiovascular disease during pregnancy, particularly in the context of peripartum cardiomyopathy (PPCM), is a topic of growing interest and debate.Before answering this question, I want to make a few points: PPCM is thought to involve a combination of factors ...